AVECHO BIOTECHNOLOGY LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.004 AUD | 0.00% |
|
0.00% | +14.29% |
| Mar. 25 | Avecho Biotechnology Begins Patient Recruitment for Phase Three Anti-Insomnia Drug Trial | MT |
| Mar. 14 | Avecho to Push Forward with Phase III Trial of Anti-Insomnia Drug | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 8.39M | - | - | - | - | - | |
| 46.81B | - | |||||
| 41.37B | ||||||
| 41.29B | ||||||
| 28.87B | ||||||
| 26.06B |
